CN103301364A - Pharmaceutical composition for treating post-stroke shoulder-hand syndrome - Google Patents
Pharmaceutical composition for treating post-stroke shoulder-hand syndrome Download PDFInfo
- Publication number
- CN103301364A CN103301364A CN2013102803537A CN201310280353A CN103301364A CN 103301364 A CN103301364 A CN 103301364A CN 2013102803537 A CN2013102803537 A CN 2013102803537A CN 201310280353 A CN201310280353 A CN 201310280353A CN 103301364 A CN103301364 A CN 103301364A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- pharmaceutical composition
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating post-stroke shoulder-hand syndrome. The composition is prepared from the following materials in percentage by weight: calyx seu fructus physalis, pawpaw, celandine, muskroot-like semiaquilegia root, aleppo avens, clinopodium polycephalum, common gendarussa herb, cortex dictamni, manchurian lilac bark, Pterocephalus hookeri, the fruit of Chinese wolfberrythe fruit, medulla of stachyurus, plantain herb, Chinese mahonia stem, Folium Sauropi, Ligusticum wallichii, kapok, loofah sponge, Chinese azalea flower, adenophora tetraphylla, lindley eupatorium, Thlaspi arvense, Paniculate Swallowwort Root, piper cubeba, semen coicis, witloof, Gorgon fruit, Morinda officinalis, Rhizoma Dioscoreae Septemlobae, prepared rehmannia root, seed of feather cockscomb, spina date seed, cocklebur fruit, Peucedanum decursivum Maxim, white hyacinth Bean, lily, Chinese azalea flower, chinaroot greenbrier, Mangnolia officinalis, herba siegesbeckiae, elecampane and perfoliote knotweed herb. The pharmaceutical composition for treating post-stroke shoulder-hand syndrome provided by the invention has the characteristics of low cost, easiness in preparation, small toxic and side effects and remarkable curative effect.
Description
Technical field
The present invention relates to drug world, specifically, relate to a kind of pharmaceutical composition for the treatment of shoulder-hand syndrome after the apoplexy.
Background technology
Shoulder-hand syndrome is owing to the series of symptoms that affected limb lacks initiatively or passive activity occurs after the apoplexy, is one of major complications of apoplexy.Patients complicated with shoulder-hand syndrome after the apoplexy directly affects patient's later stage rehabilitation and quality of life.Medical science thinks, shoulder-hand syndrome morbidity main cause is old caused by liver and kidney deficiency after the apoplexy, and imbalance of YIN and YANG, meridians lose supports, and the QI and blood Kui stagnates, and move not freely, and skin muscle arteries and veins is accidentally dropped and moistened foster and cause.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of shoulder-hand syndrome after the apoplexy.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of shoulder-hand syndrome after the apoplexy, it is made by the material of following weight proportioning: 14 parts of Calyx Seu Fructus Physaliss, 16 parts of Fructus Chaenomeliss, 17 parts of Herba Chelidoniis, 27 parts of Radix Semiaquilegiaes, 5 parts of Radix seu Herba Gei aleppici, 12 parts of Herba Clinopodii, 3 parts of Herba Gendarussaes, 10 parts of Cortex Dictamni, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 9 parts of Fructus Lycii, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 15 parts of Herba Plantaginiss, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 5 parts of Rhizoma Chuanxiongs, 4 parts of Flos Bombacis Malabaricis, 3 parts of Retinervus Luffae Fructuss, 4 parts of Flos Rhododendri Mollis, 15 parts of Radix Adenophoraes, 6 parts of 20 parts of Herba Thlaspiss of Herba Eupatorii Lindleyani, 36 parts of Radix Cynanchi Paniculatis, 5 parts of Fructus Litseae, 27 parts of Semen Coiciss, 7 parts of Herba Cichoriis, 3 parts of Semen Euryaless, 4 parts of 45 parts of Rhizoma Dioscoreae Septemlobaes of Radix Morindae Officinalis, 23 parts of Radix Rehmanniae Preparata, 3 parts of Semen Celosiae, 18 parts of Semen Ziziphi Spinosaes, 30 parts of Fructus Xanthii, 3 parts of RADIX PEUCEDANI, 7 parts of Semen Lablab Albums, 25 parts of Bulbus Liliies, 18 parts of Flos Rhododendri Mollis, 5 parts of Rhizoma Smilacis Chinensiss, 6 parts of 40 parts of Herba Siegesbeckiaes of Cortex Magnoliae Officinalis, 5 parts of 21 parts of the Radix Aucklandiae and Herba Polygoni cymosis.
Preferably, described pharmaceutical composition can be tablet, dispersible tablet, powder or decoction.
The pharmaceutical composition of shoulder-hand syndrome has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing after the treatment apoplexy of the present invention.
The specific embodiment
Embodiment 1:
Take by weighing Calyx Seu Fructus Physalis 14 grams, Fructus Chaenomelis 16 grams, Herba Chelidonii 17 grams, Radix Semiaquilegiae 27 grams, Radix seu Herba Gei aleppici 5 grams, Herba Clinopodii 12 grams, Herba Gendarussae 3 grams, Cortex Dictamni 10 grams, Cortex Syingae Amurensis 5 grams, Herba pterocephali 3 grams, Fructus Lycii 9 grams, Medulla Stachyuri (Medulla Helwingiae) 7 grams, Herba Plantaginis 15 grams, Caulis Mahoniae 3 grams, Folium Sauropi 6 grams, Rhizoma Chuanxiong 5 grams, Flos Bombacis Malabarici 4 grams, Retinervus Luffae Fructus 3 grams, Flos Rhododendri Mollis 4 grams, Radix Adenophorae 15 grams, Herba Eupatorii Lindleyani 20 gram Herba Thlaspiss 6 grams, Radix Cynanchi Paniculati 36 grams, Fructus Litseae 5 grams, Semen Coicis 27 grams, Herba Cichorii 7 grams, Semen Euryales 3 grams, Radix Morindae Officinalis 45 gram Rhizoma Dioscoreae Septemlobaes 4 grams, Radix Rehmanniae Preparata 23 grams, Semen Celosiae 3 grams, Semen Ziziphi Spinosae 18 grams, Fructus Xanthii 30 grams, RADIX PEUCEDANI 3 grams, Semen Lablab Album 7 grams, Bulbus Lilii 25 grams, Flos Rhododendri Mollis 18 grams, Rhizoma Smilacis Chinensis 5 grams, Cortex Magnoliae Officinalis 40 gram Herba Siegesbeckiaes 6 grams, the Radix Aucklandiae 21 grams and Herba Polygoni cymosi 5 grams, add 9000 ml waters, 80 ℃ of lower heating 5 hours, filter, filtrate is concentrated into 700 milliliters, namely gets decoction of the present invention.
Experimental example
Patients with shoulder-hand syndrome 32 examples after the apoplexy, male's 18 examples, women's 14 examples; Age 42-87 year, 67 years old mean age; The course of disease 1 month is with interior 11 examples, 1-3 month 17 examples, 4 examples more than 3 months; Sick position is 17 examples in the left side, right side 15 examples; Cerebral hemorrhage 8 examples, cerebral infarction 24 examples.
Decoction with preparation among the embodiment 1 is treated.Every day 3 times, each oral 70 milliliters, treated continuously 50 days.
Criterion of therapeutical effect
According to Fugl-Meyer method evaluation upper extremity exercise function.Produce effects: shoulder arthralgia disappears, main passive exercise normal, and the hands edema disappears, without the little amyotrophy of hand; Effectively: shoulder arthralgia alleviates, and joint motion is slightly limited, and the hands edema obviously alleviates, without the little amyotrophy of hand; Invalid: symptom is without obvious improvement, and the little amyotrophy of hand increases the weight of gradually.
Therapeutic outcome
After through treatment, find produce effects 23 examples among the 32 routine patients, effective 9 examples.Do not occur obvious adverse reaction in the treatment, patient's blood, urine, stool routine and hepatic and renal function inspection were showed no unusually after treatment finished.
Claims (2)
1. pharmaceutical composition for the treatment of shoulder-hand syndrome after the apoplexy is characterized in that it is made by the material of following weight proportioning: 14 parts of Calyx Seu Fructus Physaliss, 16 parts of Fructus Chaenomeliss, 17 parts of Herba Chelidoniis, 27 parts of Radix Semiaquilegiaes, 5 parts of Radix seu Herba Gei aleppici, 12 parts of Herba Clinopodii, 3 parts of Herba Gendarussaes, 10 parts of Cortex Dictamni, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 9 parts of Fructus Lycii, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 15 parts of Herba Plantaginiss, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 5 parts of Rhizoma Chuanxiongs, 4 parts of Flos Bombacis Malabaricis, 3 parts of Retinervus Luffae Fructuss, 4 parts of Flos Rhododendri Mollis, 15 parts of Radix Adenophoraes, 6 parts of 20 parts of Herba Thlaspiss of Herba Eupatorii Lindleyani, 36 parts of Radix Cynanchi Paniculatis, 5 parts of Fructus Litseae, 27 parts of Semen Coiciss, 7 parts of Herba Cichoriis, 3 parts of Semen Euryaless, 4 parts of 45 parts of Rhizoma Dioscoreae Septemlobaes of Radix Morindae Officinalis, 23 parts of Radix Rehmanniae Preparata, 3 parts of Semen Celosiae, 18 parts of Semen Ziziphi Spinosaes, 30 parts of Fructus Xanthii, 3 parts of RADIX PEUCEDANI, 7 parts of Semen Lablab Albums, 25 parts of Bulbus Liliies, 18 parts of Flos Rhododendri Mollis, 5 parts of Rhizoma Smilacis Chinensiss, 6 parts of 40 parts of Herba Siegesbeckiaes of Cortex Magnoliae Officinalis, 5 parts of 21 parts of the Radix Aucklandiae and Herba Polygoni cymosis.
2. the pharmaceutical composition of shoulder-hand syndrome after the treatment apoplexy according to claim 1 is characterized in that, described pharmaceutical composition can be tablet, dispersible tablet, powder or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310280353.7A CN103301364B (en) | 2013-07-05 | 2013-07-05 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310280353.7A CN103301364B (en) | 2013-07-05 | 2013-07-05 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103301364A true CN103301364A (en) | 2013-09-18 |
| CN103301364B CN103301364B (en) | 2014-06-18 |
Family
ID=49127370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310280353.7A Expired - Fee Related CN103301364B (en) | 2013-07-05 | 2013-07-05 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103301364B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705748A (en) * | 2014-01-02 | 2014-04-09 | 张建雷 | Medicament for treating shoulder-hand syndrome |
| CN103736046A (en) * | 2013-12-26 | 2014-04-23 | 柳州市中医院 | Medicament rod for treating shoulder-hand syndrome after stroke and preparation method thereof |
| CN104398828A (en) * | 2014-01-02 | 2015-03-11 | 王芳 | Medicament for treating shoulder-hand syndrome |
| CN106110208A (en) * | 2016-08-09 | 2016-11-16 | 隋荣玲 | The Traditional Chinese medicinal spray of Combined with Acupuncture treatment post-stroke shoulder-hand syndrome and preparation method |
| CN106214990A (en) * | 2016-09-18 | 2016-12-14 | 湖南天地恒制药有限公司 | Zhuifengtougu capsules is as the application of shoulder-hand syndrome after stroke medicine |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810824A (en) * | 2010-03-16 | 2010-08-25 | 周霞 | Chinese medicament for curing post-stroke hand-shoulder syndrome |
| CN103083451A (en) * | 2013-02-21 | 2013-05-08 | 河南中医学院 | Traditional Chinese medical ointment for treating shoulder-hand syndrome as well as preparation method thereof |
| CN103157091A (en) * | 2013-03-22 | 2013-06-19 | 王辉 | Drug for treating empyrosis |
| CN103157085A (en) * | 2013-03-22 | 2013-06-19 | 孟秀云 | Drug for treating fracture |
-
2013
- 2013-07-05 CN CN201310280353.7A patent/CN103301364B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810824A (en) * | 2010-03-16 | 2010-08-25 | 周霞 | Chinese medicament for curing post-stroke hand-shoulder syndrome |
| CN103083451A (en) * | 2013-02-21 | 2013-05-08 | 河南中医学院 | Traditional Chinese medical ointment for treating shoulder-hand syndrome as well as preparation method thereof |
| CN103157091A (en) * | 2013-03-22 | 2013-06-19 | 王辉 | Drug for treating empyrosis |
| CN103157085A (en) * | 2013-03-22 | 2013-06-19 | 孟秀云 | Drug for treating fracture |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103736046A (en) * | 2013-12-26 | 2014-04-23 | 柳州市中医院 | Medicament rod for treating shoulder-hand syndrome after stroke and preparation method thereof |
| CN103705748A (en) * | 2014-01-02 | 2014-04-09 | 张建雷 | Medicament for treating shoulder-hand syndrome |
| CN104398828A (en) * | 2014-01-02 | 2015-03-11 | 王芳 | Medicament for treating shoulder-hand syndrome |
| CN103705748B (en) * | 2014-01-02 | 2015-09-09 | 张建雷 | A kind of medicament for the treatment of shoulder-hand syndrome |
| CN106110208A (en) * | 2016-08-09 | 2016-11-16 | 隋荣玲 | The Traditional Chinese medicinal spray of Combined with Acupuncture treatment post-stroke shoulder-hand syndrome and preparation method |
| CN106214990A (en) * | 2016-09-18 | 2016-12-14 | 湖南天地恒制药有限公司 | Zhuifengtougu capsules is as the application of shoulder-hand syndrome after stroke medicine |
| CN106214990B (en) * | 2016-09-18 | 2019-03-12 | 湖南天地恒一制药有限公司 | Application of the Zhuifengtougu capsules as shoulder-hand syndrome after stroke therapeutic agent |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103301364B (en) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101757572B (en) | Traditional Chinese medicine composition for treating infantile cerebral palsy and preparation method thereof | |
| CN101485833B (en) | Chinese medicinal composition for treating impotence and premature ejaculation | |
| CN101209337B (en) | Medicinal liquor for treating rheumatism and rheumatoid | |
| CN103301364B (en) | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome | |
| CN100473411C (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
| CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
| CN103784667A (en) | Externally-used Chinese herbal medicine liquor for treating rheumatoidbone disease and preparation and usage method thereof | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN104800626A (en) | Preparation method for medicine for treating renal failure | |
| CN103405574B (en) | Medicinal composition for treating hypertension | |
| CN101357187A (en) | Medicine for treating the prostatitis | |
| CN104667101A (en) | Decoction medicine for treating enuresis and preparation method of decoction medicine | |
| CN103599473A (en) | Traditional Chinese medicinal composition for treating dizziness and chest distress | |
| CN101874851B (en) | Traditional Chinese medicine for treating chronic infectious arthritis | |
| CN102218131A (en) | External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN102552772B (en) | Traditional Chinese medicine used for treating chronic cough lung deficiency | |
| CN101862430B (en) | Chinese medicament for treating femoral head necrosis and preparation method thereof | |
| CN101444564A (en) | Liquid medicine for treating hemorrhoids | |
| CN103599508A (en) | Traditional Chinese medicine composition for treating pediatric uremia | |
| CN101518625B (en) | Drug for treating toxuria | |
| CN102949612B (en) | A kind of preparation for being used to treat neck and lumbar pain | |
| CN102370838A (en) | Kidney-invigorating and tendon-reinforcing double-phase capsule | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN103656495B (en) | Salvia miltiorrhiza phytic acid electuary |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: YU ZHIQIANG Free format text: FORMER OWNER: LI HUA Effective date: 20140512 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yu Zhiqiang Inventor before: Li Hua |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 272137 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI HUA TO: YU ZHIQIANG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140512 Address after: Hospital of TCM of Jining No. 3 Ring Road 272137 in Shandong province Jining City Applicant after: Yu Zhiqiang Address before: Building 100083 Beijing city Haidian District Yihai Qinghua East Road, Room 608 Applicant before: Li Hua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140618 Termination date: 20150705 |
|
| EXPY | Termination of patent right or utility model |